TORONTO / Aug 21, 2025 / Business Wire / Satellos Bioscience Inc . (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, announced today that members of its senior management team will participate in the following investor events in September: Wells Fargo Healthcare Conference Format: Participation in 1x1... Read More